CBER BEST Initiative 3 - Data Sources for Surveillance of Biologics
Active Master IDIQ Awarded
- Federal agency
-
Food and Drug Administration
- Awardees
- 4
- Task orders
- 8
- Obligated
- $48,668,557
Vehicle facts
- Opportunity
-
- Center for Biologics Evaluation and Research (CBER), Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics Pre-Solicitation · 75F40124R00002 · Posted Jun 30, 2024
- Agency
-
- Food and Drug Administration Department of Health and Human Services
- Combined task order value
-
- $48,668,557 Current, with exercised options
- $49,435,160 Potential, with all options
- Last date to order 42% complete
- Shared ceiling 65% used
- $75,000,000.00
IDV award and task order details come from SAM.gov/FPDS.
About this vehicle
The Food and Drug Administration's Center for Biologics Evaluation and Research established this multiple-award Master IDIQ on September 26, 2024, to procure large-scale, longitudinal health care data sources for surveillance of biologic products, with ordering authority extending through September 29, 2029. The vehicle carries a $75 million shared ceiling and is unrestricted, full and open competition with no set-aside.
Five task orders worth $25.7 million in combined potential value have been issued since award, with $24.9 million obligated (97% of potential value). The pace of ordering has accelerated: two orders in 2024, three in 2025, indicating sustained customer demand. Ordering authority remains active for the next three years, though the high obligation rate relative to the shared ceiling suggests limited room for additional work unless the customer exercises discretionary ceiling adjustments.
The solicitation required contractors to be primary data sources themselves—health insurers, payers, or providers—capable of delivering distributed access to administrative claims data, electronic health record data, and full medical charts covering tens of millions of U.S. patients with longitudinal coverage. Task orders are priced on a Time and Materials basis with completion dates through September 2026. Representative order values range from $1.4 million to $8.3 million, reflecting variation in scope and performance duration.
Iqvia Government Solutions Inc. holds the largest share, with two orders worth $10.6 million combined potential value. The Lewin Group, Inc. and CVS Healthspire Payor & Life Sciences LLC each hold one and two orders respectively, with combined potential values of $8.3 million and $6.9 million. All customer activity funds FDA programs exclusively. Competition is tightly concentrated: three firms account for 100% of awarded orders, and the top firm (Iqvia) alone represents roughly 41% of combined potential value. All five orders carry no set-aside designation. The vehicle draws from a limited contractor universe constrained by the requirement to be an existing data source; this structural limitation will persist throughout the ordering period.
IDV awards
Latest task orders
Top awardees by obligations
| Rank | Awardee | Obligated | Share |
|---|---|---|---|
| 1 | Iqvia Government Solutions Inc. | $18,726,385 | 38% |
| 2 | The Lewin Group, Inc. | $16,102,809 | 33% |
| 3 | CVS Healthspire Payor & Life Sciences LLC | $13,839,363 | 28% |
Top funding agencies by obligations
| Rank | Funding agency | Obligated | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $48,668,557 | 100% |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2026 | $23,749,629 |
| FY2025 | $11,273,319 |
| FY2024 | $13,645,610 |
Quick answers
What is the CBER BEST Initiative 3 - Data Sources for Surveillance of Biologics contract vehicle?
CBER BEST Initiative 3 - Data Sources for Surveillance of Biologics is an indefinite delivery, indefinite quantity (IDIQ) contract vehicle run by Food and Drug Administration (Department of Health and Human Services), awarded on September 26, 2024.
Which companies hold CBER BEST Initiative 3 - Data Sources for Surveillance of Biologics?
4 companies hold CBER BEST Initiative 3 - Data Sources for Surveillance of Biologics's IDV awards, one each. The latest went to Acumen LLC on September 27, 2024. The awardees whose task orders obligated the most are Iqvia Government Solutions Inc., The Lewin Group, Inc. and CVS Healthspire Payor & Life Sciences LLC.
How much has been spent through CBER BEST Initiative 3 - Data Sources for Surveillance of Biologics?
8 task orders have been placed under CBER BEST Initiative 3 - Data Sources for Surveillance of Biologics, obligating $48,668,557.
What is the shared ceiling of CBER BEST Initiative 3 - Data Sources for Surveillance of Biologics?
CBER BEST Initiative 3 - Data Sources for Surveillance of Biologics's shared ceiling is $75,000,000; its task orders have used 65% of it.
Which agencies use CBER BEST Initiative 3 - Data Sources for Surveillance of Biologics the most?
The departments whose task orders under CBER BEST Initiative 3 - Data Sources for Surveillance of Biologics obligated the most are Department of Health and Human Services ($48,668,557).
How much was obligated through CBER BEST Initiative 3 - Data Sources for Surveillance of Biologics in fiscal year 2025?
Task orders under CBER BEST Initiative 3 - Data Sources for Surveillance of Biologics obligated $11,273,319 in fiscal year 2025.
On GovTribe
See this vehicle's full record
- Every IDV award and task order
- Funding by agency, awardee, NAICS and set-aside
- Teaming partners on this vehicle
- Ask GovTribe AI about this vehicle